TNNI3 Antikörper (AA 80-95)
Kurzübersicht für TNNI3 Antikörper (AA 80-95) (ABIN5775635)
Target
Alle TNNI3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 80-95
-
Produktmerkmale
- Cultured in vitro under conditions free from animal-derived components
-
Aufreinigung
- Protein A/G affinity column
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Sandwich immunoassay (Capture-Detection):
(32CD + 6D11) - 5C7
32CD - 5C7
31D - 32CD
5C7 - 6D11
(3C9 + 32CD) - (5C7 + 31D) -
Kommentare
-
In Vitro Diagnostics (IVD)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 4 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.03 % Proclin 300
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.
-
-
- TNNI3 (Cardiac Troponin I (TNNI3))
-
Andere Bezeichnung
- cTnI
-
Hintergrund
- Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).
Target
-